8-K: Health In Tech Reports Q2 2026 Results: Revenue Down, Net Loss Widens

Health In Tech announced its second quarter 2026 financial results, reporting a decrease in revenue and a net loss, though it highlighted growth in distribution partners and a substantial revenue pipeline.

Summary

• Health In Tech reported Q2 2026 revenue of $8.1 million, a decrease from $9.3 million in Q2 2025. First-half 2026 revenue was $16.8 million, down from $17.3 million in the prior year.
• The company reported a net loss of $2.5 million for Q2 2026, or $(0.04) per diluted share, compared to a net income of $0.6 million in Q2 2025. First-half 2026 net loss was $4.1 million.
• Adjusted EBITDA was $(1.3) million for Q2 2026 and $(2.6) million for the first half of 2026.
• Distribution partners grew by 19.9% year-over-year to 933 as of June 30, 2026.
• Contracted Revenue totaled $32.3 million for first-half 2026, with $17.3 million recognized as GAAP revenue.
• Pipeline Revenue was $66.3 million as of July 31, 2026, with an expected conversion rate of 15% to 40% for policies in quoting or binding status.
• The company reaffirmed its full-year 2026 revenue guidance of $45 million to $50 million.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to a significant revenue decline and net loss, despite growth in distribution partners and future revenue visibility.

Positives

• Distribution partners increased by 19.9% year-over-year to 933 as of June 30, 2026.
• Contracted Revenue reached $32.3 million for the first half of 2026, indicating future revenue streams.
• Pipeline Revenue stood at $66.3 million as of July 31, 2026, suggesting potential for future contracted revenue.
• The company reaffirmed its full-year 2026 revenue guidance of $45 million to $50 million.
• Secured first employer group for the Three-Year Rate Stabilization Program.
• Engaged with high-profile governmental organizations evaluating participation in the Three-Year Rate Stabilization Program.
• On track to launch HitRix, the next-generation marketplace platform, in the second half of 2026.

Negatives

• Q2 2026 revenue decreased to $8.1 million from $9.3 million in Q2 2025.
• First-half 2026 revenue decreased to $16.8 million from $17.3 million in the prior year.
• Reported a net loss of $2.5 million for Q2 2026, compared to a net income of $0.6 million in Q2 2025.
• First-half 2026 net loss was $4.1 million, compared to a net income of $1.1 million in the prior year.
• Adjusted EBITDA was negative at $(1.3) million for Q2 2026 and $(2.6) million for the first half of 2026.
• Significant increase in Accounts receivable, net from $756,288 to $8,546,307.
• Substantial increase in Accounts payable and accrued expenses from $4,188,811 to $9,907,370.

Risks

• Forward-looking statements involve known and unknown risks, uncertainties, and other factors that could cause actual results to differ materially.
• The conversion rate of Pipeline Revenue (15% to 40%) is an estimate and may not be achieved.
• The success of the Three-Year Rate Stabilization Program and its launch in the capital markets is subject to various factors.
• The launch of HitRix platform is subject to development and market adoption risks.

Future Outlook

The company reaffirmed its full-year 2026 revenue guidance of $45 million to $50 million. It expects to continue expanding Pipeline Revenue through new product launches and system enhancements. The launch of the HitRix marketplace platform is anticipated in the second half of 2026. The Three-Year Rate Stabilization Program is progressing towards a capital markets launch.

Management Comments

• "We continued to execute against our long-term growth strategy during the quarter by investing in sales, marketing, and key talent, supported in part by the capital raised through our recent PIPE financing."
• "These investments are designed to expand our distribution network, accelerate product innovation, and strengthen our execution capabilities."
• "Our contracted book of business continued to grow, providing greater visibility into future revenue."
• "We believe Contracted Revenue and Pipeline Revenue are meaningful operating metrics that complement our GAAP financial results by illustrating the strength of our sales pipeline, the pace of customer conversion, and our expected revenue trajectory."
• "We also made meaningful progress on several strategic initiatives that we believe position the Company for its next phase of growth."
• "During the quarter, we contractually secured our first employer group for the Three-Year Rate Stabilization Program, a differentiated solution designed to provide employers with greater predictability in stop-loss pricing over a multi-year period."
• "As we execute on our strategic roadmap, we remain on track to launch HitRix, our next-generation marketplace platform, in the second half of 2026."

Industry Context

StockSavvy.ai notes that Health In Tech operates in the InsurTech sector, leveraging AI for underwriting and platform solutions in the self-funded health insurance market. The company's focus on expanding distribution partners and developing advanced platforms like HitRix aligns with industry trends towards digitalization and AI integration to improve efficiency and transparency in insurance processes. However, the reported revenue decline and net loss indicate significant challenges in monetizing this growth and navigating a competitive landscape.

Comparison to Industry Standards

• The reported Q2 2026 revenue of $8.1 million and first-half revenue of $16.8 million represent a year-over-year decline, which is contrary to growth expectations for many InsurTech companies that have seen increased adoption of digital solutions.
• The net loss of $2.5 million in Q2 2026 and $4.1 million in the first half, coupled with negative Adjusted EBITDA, suggests that the company is not yet achieving profitability, a key benchmark for sustainable growth in the sector.
• While distribution partner growth of 19.9% is positive, it has not translated into top-line revenue growth, indicating potential issues with conversion rates or the value of new partnerships compared to established ones.
• Competitors in the InsurTech space, such as Oscar Health or Clover Health, are also facing profitability challenges but often report higher revenue figures or different growth trajectories based on their specific market focus and scale.

Stakeholder Impact

• Shareholders may be concerned by the decline in revenue and widening net loss, despite positive indicators in partner growth and future revenue visibility.
• Employees may face uncertainty due to the company's financial performance and ongoing investments.
• Customers (employers and brokers) may benefit from the development of new programs like the Three-Year Rate Stabilization Program and the HitRix platform, offering greater predictability and efficiency.

Next Steps

• Continue expanding Pipeline Revenue through new product launches and system enhancements.
• Launch HitRix, the next-generation marketplace platform, in the second half of 2026.
• Provide additional updates on governmental organizations evaluating participation in the Three-Year Rate Stabilization Program.
• Advance the Three-Year Rate Stabilization Program toward its launch in the capital markets.

Key Dates

Recommendation

The significant year-over-year decline in revenue and the shift from net income to a substantial net loss in Q2 2026, coupled with negative Adjusted EBITDA, indicate worsening financial performance. While there are positive developments in distribution growth and future revenue visibility (contracted and pipeline revenue), these have not yet translated into positive financial results. The company's ability to achieve its full-year revenue guidance and successfully launch new initiatives like HitRix and the Rate Stabilization Program remains uncertain given the current financial trajectory. Therefore, a sell recommendation is warranted based on the deteriorating financial health and execution risks.

Keywords

InsurTech, AI-enabled, Stop-loss insurance, Self-funded health plans, Underwriting, Distribution partners, Revenue guidance, Marketplace platform